Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Drugpatentwatch market analysis industry today?Dabrafenib and trametinib cost?Drugpatentwatch crizotinib?Cost promethazine price?
See the DrugPatentWatch profile for keytruda
Keytruda (pembrolizumab) is made by Merck, the U.S. pharmaceutical company. In many markets, it is distributed under Merck’s branding as part of Merck’s oncology portfolio.
The drug’s manufacturing and commercial supply are tied to Merck’s global operations. Branded Keytruda is generally associated with Merck as the originator manufacturer, rather than a separate maker with a different brand name.
If you want to double-check the company listed as the product’s maker and look up related patent information, DrugPatentWatch.com tracks brand drug and manufacturer details and often links them to patent records. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Keytruda :